227 related articles for article (PubMed ID: 10627641)
1. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation.
McCarthy AJ; Kingman HM; Kelly C; Taylor GS; Caul EO; Grier D; Moppett J; Foot AB; Cornish JM; Oakhill A; Steward CG; Pamphilon DH; Marks DI
Bone Marrow Transplant; 1999 Dec; 24(12):1315-22. PubMed ID: 10627641
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
3. [Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].
Kalayoglu Beşişik S; Sen F; Midilli K; Yilmaz G; Ozsüt H; Calangu S; Sargin D
Mikrobiyol Bul; 2008 Apr; 42(2):359-64. PubMed ID: 18697436
[TBL] [Abstract][Full Text] [Related]
4. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
Chakrabarti S; Collingham KE; Holder K; Fegan CD; Osman H; Milligan DW
Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
Small TN; Casson A; Malak SF; Boulad F; Kiehn TE; Stiles J; Ushay HM; Sepkowitz KA
Bone Marrow Transplant; 2002 Feb; 29(4):321-7. PubMed ID: 11896429
[TBL] [Abstract][Full Text] [Related]
6. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
[TBL] [Abstract][Full Text] [Related]
7. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment.
Abdallah A; Rowland KE; Schepetiuk SK; To LB; Bardy P
Bone Marrow Transplant; 2003 Jul; 32(2):195-203. PubMed ID: 12838285
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review.
Khushalani NI; Bakri FG; Wentling D; Brown K; Mohr A; Anderson B; Keesler C; Ball D; Bernstein ZP; Bernstein SH; Czuczman MS; Segal BH; McCarthy PL
Bone Marrow Transplant; 2001 May; 27(10):1071-3. PubMed ID: 11438823
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.
Ghosh S; Champlin RE; Ueno NT; Anderlini P; Rolston K; Raad I; Kontoyiannis D; Jacobson K; Luna M; Tarrand J; Whimbey E
Bone Marrow Transplant; 2001 Aug; 28(3):271-5. PubMed ID: 11535995
[TBL] [Abstract][Full Text] [Related]
11. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
[TBL] [Abstract][Full Text] [Related]
12. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
Sparrelid E; Ljungman P; Ekelöf-Andström E; Aschan J; Ringdén O; Winiarski J; Wåhlin B; Andersson J
Bone Marrow Transplant; 1997 May; 19(9):905-8. PubMed ID: 9156264
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
Wendt CH; Hertz MI
Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
[TBL] [Abstract][Full Text] [Related]
15. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
Liu V; Dhillon GS; Weill D
Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT.
Anak S; Atay D; Unuvar A; Garipardic M; Agaoglu L; Ozturk G; Karakas Z; Devecioglu O
Pediatr Pulmonol; 2010 Mar; 45(3):307-11. PubMed ID: 20146398
[TBL] [Abstract][Full Text] [Related]
19. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Ljungman P; Ward KN; Crooks BN; Parker A; Martino R; Shaw PJ; Brinch L; Brune M; De La Camara R; Dekker A; Pauksen K; Russell N; Schwarer AP; Cordonnier C
Bone Marrow Transplant; 2001 Sep; 28(5):479-84. PubMed ID: 11593321
[TBL] [Abstract][Full Text] [Related]
20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
